WIRTH PETER

Insider Reports History

Location
Boston, MA
Signature
/s/ Bruce Blefeld, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by WIRTH PETER:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Zai Lab Ltd Director American Depositary Shares 394K $8.17M $21.33 18 Jun 2025 Direct
Syros Pharmaceuticals, Inc. Director Common Stock 16K $79.2K $4.95 05 Jun 2024 Direct
Syros Pharmaceuticals, Inc. Director Stock Option (right to buy) 6K 05 Jun 2024 Direct
Forma Therapeutics Holdings, Inc. Director Common Stock 0 $5.05 14 Oct 2022 Direct
Forma Therapeutics Holdings, Inc. Director Stock Option (Right to Buy) 0 14 Oct 2022 Direct

Insider Reports Filed by WIRTH PETER

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ZLAB Zai Lab Ltd 18 Jun 2025 1 $0 4 Director 23 Jun 2025, 16:11
ZLAB Zai Lab Ltd 18 Jun 2024 1 $0 4 Director 20 Jun 2024, 17:01
SYRS Syros Pharmaceuticals, Inc. 05 Jun 2024 2 $0 4 Director 07 Jun 2024, 16:30
ZLAB Zai Lab Ltd 29 Jun 2023 1 $500K 4 Director 30 Jun 2023, 16:06
SYRS Syros Pharmaceuticals, Inc. 01 Jun 2023 2 $0 4 Director 02 Jun 2023, 16:26
ZLAB Zai Lab Ltd 08 Dec 2022 2 -$278K 4 Director 09 Dec 2022, 15:05
FMTX Forma Therapeutics Holdings, Inc. 14 Oct 2022 7 $0 4 Director 14 Oct 2022, 16:06
SYRS Syros Pharmaceuticals, Inc. 16 Sep 2022 2 $0 4 Director 19 Sep 2022, 17:15
FMTX Forma Therapeutics Holdings, Inc. 08 Jun 2022 2 $0 4 Director 09 Jun 2022, 17:33
SYRS Syros Pharmaceuticals, Inc. 01 Jun 2022 1 $0 4 Director 02 Jun 2022, 19:09
ZLAB Zai Lab Ltd 03 Jan 2022 1 $0 4 Director 04 Jan 2022, 20:15
ZLAB Zai Lab Ltd 08 Dec 2021 1 $285K 4/A Director 12 Dec 2022, 15:05
FMTX Forma Therapeutics Holdings, Inc. 17 Jun 2021 2 $0 4 Director 21 Jun 2021, 19:02
SYRS Syros Pharmaceuticals, Inc. 08 Jun 2021 1 $0 4 Director 10 Jun 2021, 17:30